{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:48:48Z","timestamp":1791650928768,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Dysglycaemia, defined as type 2 diabetes mellitus (T2DM) or impaired glucose tolerance (IGT), increases the cardiovascular risk and prognosis. INTERASPIRE performed in 14 countries across 6 WHO regions evaluated guideline adherence and management of patients with coronary artery disease (CAD) and dysglycaemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 4,548 CAD patients (18\u201380\u00a0years) were interviewed 6\u00a0months\u20132\u00a0years after hospital admission. All without diabetes were eligible for an oral glucose test (OGTT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overall, 1990 (44%) had known T2DM. The OGTT revealed that 808 (40%) had previously unknown dysglycaemia (T2DM 12% and IGT 28%). Two thirds of all dysglycaemic patients were obese. A similar proportion reported low physical activity and only one third received dietary advice. Only half of dysglycemic patients were prescribed all guideline recommended cardioprotective drugs. A majority did not reach recommended blood pressure, lipids or HbA1c targets. Only 16% had attended a diabetes education program.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The INTERASPIRE study shows that screening for glucose perturbations in coronary patients is inadequate, achievement of lifestyle recommendations suboptimal and pharmacological management insufficient resulting in a poor risk factor control. Patients with coronary disease, especially those with glucose perturbations require professional support to achieve healthier lifestyles, and prescription of all cardioprotective medications to achieve guideline targets.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02878-3","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:11:59Z","timestamp":1754914319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions"],"prefix":"10.1186","volume":"24","author":[{"given":"Safi Moayad","family":"Al-Azzawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John William","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Adamska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Erlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ganly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Kotseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mellbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Vihervaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Almahmeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ade Meidian","family":"Ambari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam","family":"Hasan-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney M.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syadi Mahmood","family":"Zuhdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Makubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amam Chinyere","family":"Mbakwem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Mbau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis Navarro","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu Samuel","family":"Ogah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah Nyainda","family":"Ogola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalberto","family":"Quintero\u2013Baiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Umar","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ines Sosa","family":"Liprandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Wei Chieh","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Alberto Urina","family":"Triana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tee Joo","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Bacquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"2878_CR1","unstructured":"World Heart Federation, 2023; World-heart-federation.org\/wp-content\/uploads\/World-Heart-Report-2023.pdf. Accessed October 2024."},{"issue":"1","key":"2878_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/gh.1288","volume":"19","author":"M Di Cesare","year":"2024","unstructured":"Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, et al. The heart of the world. Glob Heart. 2024;19(1):11.","journal-title":"Glob Heart"},{"key":"2878_CR3","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2021","unstructured":"International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels: Belgium, International Diabetes Federation; 2021.","edition":"10"},{"issue":"11","key":"2878_CR4","doi-asserted-by":"publisher","first-page":"e0142045","DOI":"10.1371\/journal.pone.0142045","volume":"10","author":"A George","year":"2015","unstructured":"George A, Bhatia RT, Buchanan GL, Whiteside A, Moisey RS, Beer SF, et al. Impaired glucose tolerance or newly diagnosed diabetes mellitus diagnosed during admission adversely affects prognosis after myocardial infarction: an observational study. PLoS ONE. 2015;10(11):e0142045.","journal-title":"PLoS ONE"},{"issue":"29","key":"2878_CR5","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/eurheartj\/ehy233","volume":"39","author":"S Chattopadhyay","year":"2018","unstructured":"Chattopadhyay S, George A, John J, Sathyapalan T. Adjustment of the GRACE score by 2-hour post-load glucose improves prediction of long-term major adverse cardiac events in acute coronary syndrome in patients without known diabetes. Eur Heart J. 2018;39(29):2740\u20135.","journal-title":"Eur Heart J"},{"issue":"9","key":"2878_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2337\/dc17-0245","volume":"40","author":"B Shahim","year":"2017","unstructured":"Shahim B, De Bacquer D, De Backer G, Gyberg V, Kotseva K, Mellbin L, et al. The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA(1c) in patients with coronary artery disease: a report from EUROASPIRE IV: A survey from the European society of cardiology. Diabetes Care. 2017;40(9):1233\u201340.","journal-title":"Diabetes Care"},{"key":"2878_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Classification and diagnosis of diabetes standards of care in diabetes-2023. Diabetes Care. 2023;46:19\u201340.","journal-title":"Diabetes Care."},{"issue":"39","key":"2878_CR8","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140.","journal-title":"Eur Heart J"},{"key":"2878_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-015-0296-y","volume":"14","author":"V Gyberg","year":"2015","unstructured":"Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, et al. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol. 2015;14:133\u201344.","journal-title":"Cardiovasc Diabetol"},{"issue":"19","key":"2878_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/eurheartj\/ehv008","volume":"36","author":"V Gyberg","year":"2015","unstructured":"Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, Sundvall J, et al. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV\u2013a survey from the European Society of Cardiology. Eur Heart J. 2015;36(19):1171\u20137.","journal-title":"Eur Heart J"},{"issue":"4","key":"2878_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2337\/dc19-2165","volume":"43","author":"G Nniniannini","year":"2020","unstructured":"Nniniannini G, De Bacquer D, De Backer G, Kotseva K, Mellbin L, Wood D, et al. Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease-a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V. Diabetes Care. 2020;43(4):726\u201333.","journal-title":"Diabetes Care."},{"issue":"2","key":"2878_CR12","doi-asserted-by":"publisher","first-page":"e016835","DOI":"10.1161\/JAHA.120.016835","volume":"10","author":"AJ Nelson","year":"2021","unstructured":"Nelson AJ, Ardissino M, Haynes K, Shambhu S, Eapen ZJ, McGuire DK, et al. Gaps in evidence-based therapy use in insured patients in the United States with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. J Am Heart Assoc. 2021;10(2):e016835.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2878_CR13","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","volume":"2","author":"D Flood","year":"2021","unstructured":"Flood D, Seiglie JA, Dunn M, Tschida S, Theilmann M, Marcus ME, et al. The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev. 2021;2(6):e340\u201351.","journal-title":"Lancet Healthy Longev"},{"issue":"10","key":"2878_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11886-021-01568-2","volume":"23","author":"JW McEvoy","year":"2021","unstructured":"McEvoy JW, Jennings C, Kotseva K, De Backer G, De Bacquer D, Erlund I, et al. INTERASPIRE: an international survey of coronary patients; their cardiometabolic, renal and biomarker status; and the quality of preventive care delivered in All WHO regions. Curr Cardiol Rep. 2021;23(10):136.","journal-title":"Curr Cardiol Rep"},{"issue":"39","key":"2878_CR15","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1093\/eurheartj\/ehae558","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I, et al. Variation in secondary prevention of coronary heart disease: the INTERASPIRE study. Eur Heart J. 2024;45(39):4184\u201396.","journal-title":"Eur Heart J"},{"issue":"19","key":"2878_CR16","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"key":"2878_CR17","unstructured":"World Health Organization. Definitions and diagnosis of diabetes mellitus and intermediate hyperglycaemia [Internet] 21 April 2006. available from https:\/\/www.who.int\/publications\/i\/item\/definition-and-diagnosis-of-diabetes-mellitus-and-intermediate-hyperglycaemia. Accessed 16 Feb 2024."},{"issue":"15","key":"2878_CR18","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1177\/2047487320911845","volume":"28","author":"D Hansen","year":"2021","unstructured":"Hansen D, Mellbin L, Cosentino F, De Bacquer D, Grobbee D, Van Ryckeghem L, Standl E, Beulens JWJ. High awareness of diabetes as a key cardiovascular risk factor among healthcare professionals but suboptimal treatment: results from a survey of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021;28(15):e19\u201321.","journal-title":"Eur J Prev Cardiol"},{"key":"2878_CR19","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404:2077\u201393.","journal-title":"Lancet"},{"issue":"1","key":"2878_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1309\/AJCPQ23GTTMLAEVL","volume":"141","author":"JM Rhea","year":"2014","unstructured":"Rhea JM, Molinaro R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol. 2014;141(1):5\u201316.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2878_CR21","doi-asserted-by":"publisher","first-page":"e0171315","DOI":"10.1371\/journal.pone.0171315","volume":"12","author":"G Cavagnolli","year":"2017","unstructured":"Cavagnolli G, Pimentel AL, Freitas PA, Gross JL, Camargo JL. Effect of ethnicity on HbA1c levels in individuals without diabetes: systematic review and meta-analysis. PLoS One. 2017;12(2):e0171315. https:\/\/doi.org\/10.1371\/journal.pone.0171315.","journal-title":"PLoS One."},{"key":"2878_CR22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2213-8587(24)00201-8","volume":"12","author":"G Ferrannini","year":"2024","unstructured":"Ferrannini G, Tuomilehto J, De Backer G, Kotseva K, Mellbin L, Schnell O, et al. Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies. Lancet Diabetes Endocrinol. 2024;12:790\u20138.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2878_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/CIRCULATIONAHA.119.041730","volume":"140","author":"SV Arnold","year":"2019","unstructured":"Arnold SV, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Mues KE, et al. Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease. Circulation. 2019;140(7):618\u201320.","journal-title":"Circulation"},{"issue":"2","key":"2878_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.gheart.2015.04.003","volume":"10","author":"P Perel","year":"2015","unstructured":"Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation roadmap for secondary prevention of cardiovascular disease. Glob Heart. 2015;10(2):99\u2013110.","journal-title":"Glob Heart"},{"issue":"2","key":"2878_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2019","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2019;41(2):255\u2013323.","journal-title":"Eur Heart J"},{"issue":"9","key":"2878_CR26","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines. Circulation. 2023;148(9):e9\u2013119.","journal-title":"Circulation"},{"issue":"2","key":"2878_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/HJR.0b013e3282f335d0","volume":"15","author":"M Anselmino","year":"2008","unstructured":"Anselmino M, Malmberg K, Ohrvik J, Ryd\u00e9n L. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur J Cardiovasc Prev Rehabil. 2008;15(2):216\u201323.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"5","key":"2878_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2337\/dc17-1795","volume":"41","author":"MO Owolabi","year":"2018","unstructured":"Owolabi MO, Yaria JO, Daivadanam M, Makanjuola AI, Parker G, Oldenburg B, et al. Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review. Diabetes Care. 2018;41(5):1097\u2013105.","journal-title":"Diabetes Care"},{"key":"2878_CR29","doi-asserted-by":"publisher","first-page":"4930157","DOI":"10.1155\/2018\/4930157","volume":"2018","author":"G Azami","year":"2018","unstructured":"Azami G, Soh KL, Sazlina SG, Salmiah MS, Aazami S, Mozafari M, et al. Effect of a nurse-led diabetes self-management education program on glycosylated hemoglobin among adults with type 2 diabetes. J Diabetes Res. 2018;2018:4930157.","journal-title":"J Diabetes Res"},{"issue":"12","key":"2878_CR30","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.2337\/dc20-0886","volume":"43","author":"RM Anjana","year":"2020","unstructured":"Anjana RM, Mohan V, Rangarajan S, Gerstein HC, Venkatesan U, Sheridan P, et al. Contrasting associations between diabetes and cardiovascular mortality rates in low-, middle-, and high-income countries: cohort study data from 143,567 individuals in 21 countries in the PURE study. Diabetes Care. 2020;43(12):3094\u2013101.","journal-title":"Diabetes Care"},{"issue":"3","key":"2878_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2337\/dc09-0680","volume":"33","author":"SP Jansson","year":"2010","unstructured":"Jansson SP, Andersson DK, Sv\u00e4rdsudd K. Mortality trends in subjects with and without diabetes during 33 years of follow-up. Diabetes Care. 2010;33(3):551\u20136.","journal-title":"Diabetes Care"},{"issue":"3","key":"2878_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7326\/0003-4819-147-3-200708070-00167","volume":"147","author":"EW Gregg","year":"2007","unstructured":"Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007;147(3):149\u201355.","journal-title":"Ann Intern Med"},{"issue":"12","key":"2878_CR33","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00125-013-3063-1","volume":"56","author":"M Lind","year":"2013","unstructured":"Lind M, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013;56(12):2601\u20138.","journal-title":"Diabetologia"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02878-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:39:57Z","timestamp":1757374797000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02878-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2878"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02878-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approvals were obtained in all hospital centres and all patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}